Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 63 entries
Sorted by: Best Match Show Resources per page
Paroxetine-induced galactorrhea.

Indian journal of psychiatry

Gulati P, Chavan BS, Das S.
PMID: 25568484
Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529.

Drug-induced galactorrhea has been reported with agents such as antidopaminergic antiemetics, antipsychotics, etc., with few case reports of galactorrhea with selective serotonin reuptake inhibitors, including paroxetine, being reported in last few decades. Prolactin levels have been found to be...

Cite
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014;56(4):393-4doi: 10.4103/0019-5545.146529.
Gulati, P., Chavan, B. S., & Das, S. (2014). Paroxetine-induced galactorrhea. Indian journal of psychiatry, 56(4), 393-4. https://doi.org/10.4103/0019-5545.146529
Gulati, Prannay, et al. "Paroxetine-induced galactorrhea." Indian journal of psychiatry vol. 56,4 (2014): 393-4. doi: https://doi.org/10.4103/0019-5545.146529
Gulati P, Chavan BS, Das S. Paroxetine-induced galactorrhea. Indian J Psychiatry. 2014 Oct;56(4):393-4. doi: 10.4103/0019-5545.146529. PMID: 25568484; PMCID: PMC4279301.
Copy Download .nbib Format: NLM
Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.

Nature genetics

Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, Gaulton KJ, Eicher JD, Sharp SJ, Luan J, Rolfe EL, Stewart ID, Wheeler E, Willems SM, Adams C, Yaghootkar H, Forouhi NG, Khaw KT, Johnson AD, Semple RK, Frayling T, Perry JR, Dermitzakis E, McCarthy MI, Barroso I, Wareham NJ, Savage DB, Langenberg C, O'Rahilly S, Scott RA.
PMID: 28138151
Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317c.

No abstract available.

Cite
Lotta LA, Gulati P, Day FR, et al. Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2017;49(2):317doi: 10.1038/ng0217-317c.
Lotta, L. A., Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., Sharp, S. J., Luan, J., Rolfe, E. L., Stewart, I. D., Wheeler, E., Willems, S. M., Adams, C., Yaghootkar, H., Forouhi, N. G., Khaw, K. T., Johnson, A. D., Semple, R. K., Frayling, T., Perry, J. R., Dermitzakis, E., McCarthy, M. I., Barroso, I., Wareham, N. J., Savage, D. B., Langenberg, C., O'Rahilly, S., & Scott, R. A. (2017). Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nature genetics, 49(2), 317. https://doi.org/10.1038/ng0217-317c
Lotta, Luca A, et al. "Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance." Nature genetics vol. 49,2 (2017): 317. doi: https://doi.org/10.1038/ng0217-317c
Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, Gaulton KJ, Eicher JD, Sharp SJ, Luan J, Rolfe EL, Stewart ID, Wheeler E, Willems SM, Adams C, Yaghootkar H, Forouhi NG, Khaw KT, Johnson AD, Semple RK, Frayling T, Perry JR, Dermitzakis E, McCarthy MI, Barroso I, Wareham NJ, Savage DB, Langenberg C, O'Rahilly S, Scott RA. Corrigendum: Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317c. PMID: 28138151.
Copy Download .nbib Format: NLM
Evaluation of genetic diversity among aquatic and fecal isolates of .

3 Biotech

Khare N, Kaushik M, Kumar S, Gulati P.
PMID: 32030332
3 Biotech. 2020 Feb;10(2):63. doi: 10.1007/s13205-020-2066-0. Epub 2020 Jan 23.

In developing countries like India, fecal pollution of surface waters is a major threat to public and environmental health. The aim of the study was to assess serological, phylogenetic and molecular diversity among aquatic

Cite
Khare N, Kaushik M, Kumar S, et al. Evaluation of genetic diversity among aquatic and fecal isolates of . 3 Biotech. 2020;10(2):63doi: 10.1007/s13205-020-2066-0.
Khare, N., Kaushik, M., Kumar, S., & Gulati, P. (2020). Evaluation of genetic diversity among aquatic and fecal isolates of . 3 Biotech, 10(2), 63. https://doi.org/10.1007/s13205-020-2066-0
Khare, Neha, et al. "Evaluation of genetic diversity among aquatic and fecal isolates of ." 3 Biotech vol. 10,2 (2020): 63. doi: https://doi.org/10.1007/s13205-020-2066-0
Khare N, Kaushik M, Kumar S, Gulati P. Evaluation of genetic diversity among aquatic and fecal isolates of . 3 Biotech. 2020 Feb;10(2):63. doi: 10.1007/s13205-020-2066-0. Epub 2020 Jan 23. PMID: 32030332; PMCID: PMC6977805.
Copy Download .nbib Format: NLM
Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences.

International journal of biological macromolecules

Kawatra A, Dhankhar R, Gulati P.
PMID: 34920062
Int J Biol Macromol. 2022 Jan 31;196:151-162. doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 15.

Arginine deiminase is a well-recognized guanidino-modifying hydrolase that catalyzes the conversion of L-arginine to citrulline and ammonia. Their biopotential to regress tumors via amino acid deprivation therapy (AADT) has been well established. PEGylated formulation of recombinant Mycoplasma ADI is...

Cite
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2021;196:151-162doi: 10.1016/j.ijbiomac.2021.12.015.
Kawatra, A., Dhankhar, R., & Gulati, P. (2022). Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. International journal of biological macromolecules, 196151-162. https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra, Anubhuti, et al. "Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences." International journal of biological macromolecules vol. 196 (2022): 151-162. doi: https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2022 Jan 31;196:151-162. doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 15. PMID: 34920062.
Copy Download .nbib Format: NLM
Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.

PloS one

Scaglione A, Panzarino C, Modica M, Tavanelli M, Pezzano A, Grati P, Racca V, Toccafondi A, Bordoni B, Verde A, Cartella I, Castiglioni P.
PMID: 34851984
PLoS One. 2021 Dec 01;16(12):e0259927. doi: 10.1371/journal.pone.0259927. eCollection 2021.

The efficacy of cardiac rehabilitation in heart-failure patients who received a left-ventricular assist device (LVAD) instead of heart transplantation (HTx) is still unclear. This study aims to evaluate whether cardiac rehabilitation is beneficial in LVAD as HTx patients in...

Cite
Scaglione A, Panzarino C, Modica M, et al. Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device. PLoS One. 2021;16(12):e0259927doi: 10.1371/journal.pone.0259927.
Scaglione, A., Panzarino, C., Modica, M., Tavanelli, M., Pezzano, A., Grati, P., Racca, V., Toccafondi, A., Bordoni, B., Verde, A., Cartella, I., & Castiglioni, P. (2021). Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device. PloS one, 16(12), e0259927. https://doi.org/10.1371/journal.pone.0259927
Scaglione, Anna, et al. "Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device." PloS one vol. 16,12 (2021): e0259927. doi: https://doi.org/10.1371/journal.pone.0259927
Scaglione A, Panzarino C, Modica M, Tavanelli M, Pezzano A, Grati P, Racca V, Toccafondi A, Bordoni B, Verde A, Cartella I, Castiglioni P. Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device. PLoS One. 2021 Dec 01;16(12):e0259927. doi: 10.1371/journal.pone.0259927. eCollection 2021. PMID: 34851984; PMCID: PMC8635401.
Copy Download .nbib Format: NLM
Hemolytic anemia in expanded dengue syndrome (EDS).

QJM : monthly journal of the Association of Physicians

Arora N, Gulati P, Suri V, Bhalla A, Singh H.
PMID: 34850225
QJM. 2021 Nov 26; doi: 10.1093/qjmed/hcab298. Epub 2021 Nov 26.

No abstract available.

Cite
Arora N, Gulati P, Suri V, et al. Hemolytic anemia in expanded dengue syndrome (EDS). QJM. 2021;doi: 10.1093/qjmed/hcab298.
Arora, N., Gulati, P., Suri, V., Bhalla, A., & Singh, H. (2021). Hemolytic anemia in expanded dengue syndrome (EDS). QJM : monthly journal of the Association of Physicians, . https://doi.org/10.1093/qjmed/hcab298
Arora, Navneet, et al. "Hemolytic anemia in expanded dengue syndrome (EDS)." QJM : monthly journal of the Association of Physicians vol. (2021). doi: https://doi.org/10.1093/qjmed/hcab298
Arora N, Gulati P, Suri V, Bhalla A, Singh H. Hemolytic anemia in expanded dengue syndrome (EDS). QJM. 2021 Nov 26; doi: 10.1093/qjmed/hcab298. Epub 2021 Nov 26. PMID: 34850225.
Copy Download .nbib Format: NLM
Delirium in Palliative Care.

Cancers

Bramati P, Bruera E.
PMID: 34885002
Cancers (Basel). 2021 Nov 23;13(23). doi: 10.3390/cancers13235893.

Delirium, a widespread neuropsychiatric disorder in patients with terminal diseases, is associated with increased morbidity and mortality, profoundly impacting patients, their families, and caregivers. Although frequently missed, the effective recognition of delirium demands attention and commitment. Reversibility is frequently...

Cite
Bramati P, Bruera E. Delirium in Palliative Care. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235893.
Bramati, P., & Bruera, E. (2021). Delirium in Palliative Care. Cancers, 13(23), . https://doi.org/10.3390/cancers13235893
Bramati, Patricia, and Bruera, Eduardo. "Delirium in Palliative Care." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235893
Bramati P, Bruera E. Delirium in Palliative Care. Cancers (Basel). 2021 Nov 23;13(23). doi: 10.3390/cancers13235893. PMID: 34885002.
Copy Download .nbib Format: NLM
Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis.

Neurology India

Boski N, Gulati V, Raj R, Gulati P.
PMID: 34979638
Neurol India. 2021 Nov-Dec;69(6):1539-1546. doi: 10.4103/0028-3886.333497.

BACKGROUND: Multiple sclerosis is a chronic demyelinating disorder with a myriad of imaging and clinical features that overlap with number of other neurological conditions. Incorrect diagnosis poses a significant risk to patients, it may lead to delays in management,...

Cite
Boski N, Gulati V, Raj R, et al. Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis. Neurol India. 2021;69(6):1539-1546doi: 10.4103/0028-3886.333497.
Boski, N., Gulati, V., Raj, R., & Gulati, P. (2021). Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis. Neurology India, 69(6), 1539-1546. https://doi.org/10.4103/0028-3886.333497
Boski, Neha, et al. "Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis." Neurology India vol. 69,6 (2021): 1539-1546. doi: https://doi.org/10.4103/0028-3886.333497
Boski N, Gulati V, Raj R, Gulati P. Multiple Sclerosis-Minimizing Errors in Radiological Diagnosis. Neurol India. 2021 Nov-Dec;69(6):1539-1546. doi: 10.4103/0028-3886.333497. PMID: 34979638.
Copy Download .nbib Format: NLM
Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests.

Expert review of gastroenterology & hepatology

Mor P, Dahiya B, Parshad S, Gulati P, Mehta PK.
PMID: 34923892
Expert Rev Gastroenterol Hepatol. 2021 Dec 31;1-17. doi: 10.1080/17474124.2022.2021068. Epub 2021 Dec 31.

INTRODUCTION: Abdominal tuberculosis (TB) is a common epitome of extrapulmonary TB (EPTB), wherein peritoneal and intestinal TB are the most prevalent forms. Diagnosis of abdominal TB is a daunting challenge owing to variable anatomical locations, paucibacillary nature of specimens...

Cite
Mor P, Dahiya B, Parshad S, et al. Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests. Expert Rev Gastroenterol Hepatol. 2021;1-17doi: 10.1080/17474124.2022.2021068.
Mor, P., Dahiya, B., Parshad, S., Gulati, P., & Mehta, P. K. (2021). Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests. Expert review of gastroenterology & hepatology, 1-17. https://doi.org/10.1080/17474124.2022.2021068
Mor, Preeti, et al. "Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests." Expert review of gastroenterology & hepatology vol. (2021): 1-17. doi: https://doi.org/10.1080/17474124.2022.2021068
Mor P, Dahiya B, Parshad S, Gulati P, Mehta PK. Recent updates in diagnosis of abdominal tuberculosis with emphasis on nucleic acid amplification tests. Expert Rev Gastroenterol Hepatol. 2021 Dec 31;1-17. doi: 10.1080/17474124.2022.2021068. Epub 2021 Dec 31. PMID: 34923892.
Copy Download .nbib Format: NLM
Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences.

International journal of biological macromolecules

Kawatra A, Dhankhar R, Gulati P.
PMID: 34920062
Int J Biol Macromol. 2021 Dec 14; doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 14.

Arginine deiminase is a well-recognized guanidino-modifying hydrolase that catalyzes the conversion of L-arginine to citrulline and ammonia. Their biopotential to regress tumors via amino acid deprivation therapy (AADT) has been well established. PEGylated formulation of recombinant Mycoplasma ADI is...

Cite
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2021;doi: 10.1016/j.ijbiomac.2021.12.015.
Kawatra, A., Dhankhar, R., & Gulati, P. (2021). Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. International journal of biological macromolecules, . https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra, Anubhuti, et al. "Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences." International journal of biological macromolecules vol. (2021). doi: https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2021 Dec 14; doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 14. PMID: 34920062.
Copy Download .nbib Format: NLM
Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives.

Current protein & peptide science

Dhankhar R, Kawatra A, Mohanty A, Gulati P.
PMID: 33290198
Curr Protein Pept Sci. 2021;22(7):514-525. doi: 10.2174/1389203721666201207231932.

Enzyme prodrug therapy has gained momentum in recent years due to its ability to improve therapeutic index (benefits versus toxic side-effects) and efficacy of chemotherapy in cancer treatment. Inactive prodrugs used in this system are converted into active anti-cancerous...

Cite
Dhankhar R, Kawatra A, Mohanty A, et al. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives. Curr Protein Pept Sci. 2021;22(7):514-525doi: 10.2174/1389203721666201207231932.
Dhankhar, R., Kawatra, A., Mohanty, A., & Gulati, P. (2021). Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives. Current protein & peptide science, 22(7), 514-525. https://doi.org/10.2174/1389203721666201207231932
Dhankhar, Rakhi, et al. "Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives." Current protein & peptide science vol. 22,7 (2021): 514-525. doi: https://doi.org/10.2174/1389203721666201207231932
Dhankhar R, Kawatra A, Mohanty A, Gulati P. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives. Curr Protein Pept Sci. 2021;22(7):514-525. doi: 10.2174/1389203721666201207231932. PMID: 33290198.
Copy Download .nbib Format: NLM
Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences.

International journal of biological macromolecules

Kawatra A, Dhankhar R, Gulati P.
PMID: 34920062
Int J Biol Macromol. 2021 Dec 15;196:151-162. doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 15.

Arginine deiminase is a well-recognized guanidino-modifying hydrolase that catalyzes the conversion of L-arginine to citrulline and ammonia. Their biopotential to regress tumors via amino acid deprivation therapy (AADT) has been well established. PEGylated formulation of recombinant Mycoplasma ADI is...

Cite
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2021;196:151-162doi: 10.1016/j.ijbiomac.2021.12.015.
Kawatra, A., Dhankhar, R., & Gulati, P. (2021). Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. International journal of biological macromolecules, 196151-162. https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra, Anubhuti, et al. "Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences." International journal of biological macromolecules vol. 196 (2021): 151-162. doi: https://doi.org/10.1016/j.ijbiomac.2021.12.015
Kawatra A, Dhankhar R, Gulati P. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences. Int J Biol Macromol. 2021 Dec 15;196:151-162. doi: 10.1016/j.ijbiomac.2021.12.015. Epub 2021 Dec 15. PMID: 34920062.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 63 entries